Brentuximab, CAS 2088770-90-3

Product Description: Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Oh Y, et al. Part II: Prognosis and management. J Am Acad Dermatol. 2021 Nov;85(5):1093-1106.

CAS Number: 2088770-90-3

Molecular Weight: N/A

Compound Purity: 99.64

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: TNF Receptor

• Artikelnummer: MEXHY-P99151-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99151-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK